332 related articles for article (PubMed ID: 32982760)
1. Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2.
Gatti P; Ilamathi HS; Todkar K; Germain M
Front Pharmacol; 2020; 11():578599. PubMed ID: 32982760
[TBL] [Abstract][Full Text] [Related]
2. Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications.
Prasada Kabekkodu S; Chakrabarty S; Jayaram P; Mallya S; Thangaraj K; Singh KK; Satyamoorthy K
Mitochondrion; 2023 Mar; 69():43-56. PubMed ID: 36690315
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin.
Mehrzadi S; Karimi MY; Fatemi A; Reiter RJ; Hosseinzadeh A
Pharmacol Ther; 2021 Aug; 224():107825. PubMed ID: 33662449
[TBL] [Abstract][Full Text] [Related]
4. The double-membrane vesicle (DMV): a virus-induced organelle dedicated to the replication of SARS-CoV-2 and other positive-sense single-stranded RNA viruses.
Roingeard P; Eymieux S; Burlaud-Gaillard J; Hourioux C; Patient R; Blanchard E
Cell Mol Life Sci; 2022 Jul; 79(8):425. PubMed ID: 35841484
[TBL] [Abstract][Full Text] [Related]
5. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome.
Shi CS; Qi HY; Boularan C; Huang NN; Abu-Asab M; Shelhamer JH; Kehrl JH
J Immunol; 2014 Sep; 193(6):3080-9. PubMed ID: 25135833
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight.
Bhowal C; Ghosh S; Ghatak D; De R
Mol Cell Biochem; 2023 Jun; 478(6):1325-1343. PubMed ID: 36308668
[TBL] [Abstract][Full Text] [Related]
7. Role of Mitochondria in Viral Infections.
Elesela S; Lukacs NW
Life (Basel); 2021 Mar; 11(3):. PubMed ID: 33799853
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial localization of viral proteins as a means to subvert host defense.
Castanier C; Arnoult D
Biochim Biophys Acta; 2011 Apr; 1813(4):575-83. PubMed ID: 20807553
[TBL] [Abstract][Full Text] [Related]
9. Host mitochondria: more than an organelle in SARS-CoV-2 infection.
Shoraka S; Samarasinghe AE; Ghaemi A; Mohebbi SR
Front Cell Infect Microbiol; 2023; 13():1228275. PubMed ID: 37692170
[TBL] [Abstract][Full Text] [Related]
10. Exploiting Connections for Viral Replication.
Wong LH; Edgar JR; Martello A; Ferguson BJ; Eden ER
Front Cell Dev Biol; 2021; 9():640456. PubMed ID: 33816489
[TBL] [Abstract][Full Text] [Related]
11. RNA-GPS Predicts SARS-CoV-2 RNA Localization to Host Mitochondria and Nucleolus.
Wu K; Zou J; Chang HY
bioRxiv; 2020 Apr; ():. PubMed ID: 32511373
[TBL] [Abstract][Full Text] [Related]
12. Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses.
Dutta S; Das N; Mukherjee P
Front Microbiol; 2020; 11():1990. PubMed ID: 32983015
[TBL] [Abstract][Full Text] [Related]
13. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
Elife; 2020 Oct; 9():. PubMed ID: 33112236
[TBL] [Abstract][Full Text] [Related]
14. How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review.
Wang Q; Wu X; Mao Q; Gao F; Liu M; Song Z; Bian L; Liang Z
Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1119-1127. PubMed ID: 35574688
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19.
Duan C; Ma R; Zeng X; Chen B; Hou D; Liu R; Li X; Liu L; Li T; Huang H
Front Immunol; 2022; 13():946731. PubMed ID: 35844544
[TBL] [Abstract][Full Text] [Related]
17. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.
Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D
mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761
[TBL] [Abstract][Full Text] [Related]
18. Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition.
Nilsson-Payant BE; Blanco-Melo D; Uhl S; Escudero-Pérez B; Olschewski S; Thibault P; Panis M; Rosenthal M; Muñoz-Fontela C; Lee B; tenOever BR
J Virol; 2021 Apr; 95(9):. PubMed ID: 33568513
[TBL] [Abstract][Full Text] [Related]
19. High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.
Jiang L; Xiao M; Liao QQ; Zheng L; Li C; Liu Y; Yang B; Ren A; Jiang C; Feng XH
mSystems; 2023 Aug; 8(4):e0013523. PubMed ID: 37314180
[TBL] [Abstract][Full Text] [Related]
20. Targeted Mitochondrial Therapy With Over-Expressed MAVS Protein From Mesenchymal Stem Cells: A New Therapeutic Approach for COVID-19.
Babajani A; Hosseini-Monfared P; Abbaspour S; Jamshidi E; Niknejad H
Front Cell Dev Biol; 2021; 9():695362. PubMed ID: 34179022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
